Keros Therapeutics Inc (KROS) Price Prediction & ForecastKROSKeros Therapeutics Inc

Alphio's KROS stock price prediction model matches the current Keros Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.27 (+0.78%). The 1-week path is $11.17 (-0.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Keros Therapeutics Inc is not a good buy right now due to its current price of $10.66 being significantly below analyst targets, with BofA at $17 and Wells Fargo at $18. The company has a high forward P/E of 48.78, indicating potential overvaluation, and the RSI is at 29.465, suggesting it is oversold. Additionally, the stock has seen a 42.50% decline year-to-date, reflecting ongoing market concerns. The main risk is the negative earnings trend, with EPS reported at -1.45, which raises questions about profitability and future growth.

Keros Therapeutics Inc (KROS) last closed at $11.18, losing -1.93%. These facts feed the 1-day and 1-week KROS price prediction above.